Demeter announces the signing of an investment in Vulcan Energy’s Phase One Lionheart (Phase One Lionheart), a landmark transaction in the Upper Rhine Valley in Germany, which will be the first of its kind in Europe combining the production of lithium and renewable energy for industrial sites and local communities. Demeter is part of a
Lyon, October 14, 2025 – ALLERGEN ALERT, a French Deeptech startup, designs and manufactures an innovative solution for the rapid detection of food allergens and gluten, dedicated to people living with food allergies. The company has just completed a €3.6 million fundraising round with Demeter, through the Fonds d’Amorçage Industriel Métropolitain (FAIM) Lyon/Saint-Étienne, and bioMérieux,
The company holds the first authorization to market personalized veterinary phage-based treatments on EU soil. Demeter is pleased to announce that its Agrinnovation fund co-led the €25 million Series A funding round of Phagos, alongside CapAgro, Hoxton Ventures, and CapHorn, with participation from Acurio Ventures, Citizen Capital, Entrepreneur First, Founders Capital, and Station F. Founded
ALTR today announces the successful closing of its €5M seed funding round for its Flavor-First alcohol removal technology. Backed by leading investors in the beverage and technology sectors, VitiRev Innovation fund managed by Demeter leads this round, joined by Suntory Global Spirits, Jeriko (managed by Techmind), AZ Venture Capital Inc., Solvable, FTW, Bluestein Ventures, and
On 29 April, Demeter 4 Infra completed the sale to Sorégies of its stake in Les Eoliennes de Coquelicot 2, an 18.4MW wind farm developed and operated by H2air. This transaction completes the process of the sale of the portfolio held by Demeter 4 Infra, a fund launched in 2015 which invested in 5 renewable
Demeter hosted last week a very successful Club Entrepreneurs with Marc-Antoine Eyl-Mazzega as a keynote speaker. We were proud to present : · The refinancing of our EV charging assets with Groupe Caisse des Dépôts and Groupe Crédit Agricole · Brilliant pitches by our portfolio companies Phagos, Sirius Neosight, Manufacture Bois Paille, Spring and Noodis
SIRIUS NEOSIGHT, a company specializing in the isolation of Circulating Tumor Cells (CTCs) and the development of functional tests for predicting therapeutic response in oncology, has completed a €4.4 million funding round. The financing round was secured from GO CAPITAL via its GOCA3 seed fund, DEMETER through the FAIM (Fonds d’Amorçage Industriel Métropolitain) Lyon/Saint-Etienne fund,
• Cerea Partners and Demeter Investment Managers are excited to announce the signing of a major strategic agreement for a merger of equals. This union will give rise to Demea Invest, a leading player in private equity and private debt investments in startups, SMEs, and mid-sized companies, driven by an ambitious vision. • Through this
Demeter, via the Climate Infrastructure Fund (art 9 SFDR), is proud to announce its investment in ZE Energy, alongside Amundi Transition Énergétique and Sorégies, a historical shareholder reaffirming its confidence in the project. Founded in 2019, ZE Energy has developed an innovative solution for hybrid solar power plants, combining photovoltaics and energy storage, tailored for the
